Nutritional Neuroscience 2004-04-01

The effects of an essential fatty acid compound and a cholecystokinin-8 antagonist on iron deficiency induced anorexia and learning deficits.

Shlomo Yehuda, David I Mostofsky

Index: Nutr. Neurosci. 7(2) , 85-90, (2004)

Full Text: HTML

Abstract

Iron deficiency (ID) is among the most common nutritional diseases, causing deleterious effects that include decreases in cognitive function and weight loss. The ID also induces a reduction in the number and affinity of dopaminergic D2 receptors. The new finding that ID induces an increase in the pancreas cells, leads to the hypothesis that cholecystokinin-8 (CCK-8) is involved in the ID effects. The level of CCK-8 was higher among ID rats, compared with normal rats. The ID rats in our study were anorectic and performed poorly in learning tests (Morris water maze and passive avoidance learning). Essential fatty acids (EFA) mediate dopamine activity and have been found to rehabilitate learning deficits. Treatment with a fatty acid compound blocked both the learning deficits and the anorexia, while a CCK-8 antagonist was successful only against the anorectic effects.

Related Compounds

  • Loxiglumide

Related Articles:

Involvement of capsaicin-sensitive afferent nerves and cholecystokinin 2/gastrin receptors in gastroprotection and adaptation of gastric mucosa to Helicobacter pylori-lipopolysaccharide.

2004-07-01

[J. Pharmacol. Exp. Ther. 310(1) , 116-25, (2004)]

Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans.

2002-10-01

[Neurogastroenterol. Motil. 14(5) , 519-25, (2002)]

Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats.

2010-02-01

[Alcohol. Clin. Exp. Res. 34 Suppl 1 , S14-7, (2010)]

Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.

2002-03-01

[World J. Surg. 26(3) , 359-65, (2002)]

Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.

2006-03-01

[Pancreas 32(2) , 190-6, (2006)]

More Articles...